183 related articles for article (PubMed ID: 11367127)
1. FDA clarifies rules, allows combining antiretrovirals in clinical trials. Food and Drug Administration.
AIDS Treat News; 1999 Nov; (No 331):5-6. PubMed ID: 11367127
[TBL] [Abstract][Full Text] [Related]
2. FDA gives salvage therapy testing a push forward.
Bass E
AIDS Treat News; 2001 Mar; (362):3-7, 1. PubMed ID: 11569956
[TBL] [Abstract][Full Text] [Related]
3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
4. New FDA rules force drug makers to detail youth-specific effects. Food and Drug Administration.
Newsline People AIDS Coalit N Y; 1999 Jan; ():34. PubMed ID: 11367188
[TBL] [Abstract][Full Text] [Related]
5. Expanded and early access and patient assistance programs for other experimental drugs from their manufacturers.
Crit Path AIDS Proj; 1998; (No 33):43-64. PubMed ID: 11366373
[TBL] [Abstract][Full Text] [Related]
6. FDA community meeting May 16: clinical trials and viral load. Food and Drug Administration.
AIDS Treat News; 1997 May; (No 270):3. PubMed ID: 11364324
[TBL] [Abstract][Full Text] [Related]
7. FDA publishes conflict of interest rules for clinical trials. Food and Drug Administration.
James JS
AIDS Treat News; 1998 Mar; (No 290):8. PubMed ID: 11365123
[TBL] [Abstract][Full Text] [Related]
8. FDA evaluates accelerated approval process. Food and Drug Administration.
Common Factor; 1995 Apr; (no 10):18. PubMed ID: 11362343
[TBL] [Abstract][Full Text] [Related]
9. Children on losing end of access to new drugs.
AIDS Alert; 1998 Jan; 13(1):10-2. PubMed ID: 11364862
[TBL] [Abstract][Full Text] [Related]
10. Antiretrovirals for the heavily experienced patient: hefty plans to holidays.
Martinez LJ
Res Initiat Treat Action; 1999 Oct; 5(4):5-8. PubMed ID: 11366942
[TBL] [Abstract][Full Text] [Related]
11. Activism today: the Coalition for Salvage Therapy. Interview with Linda Grinberg. Interview by John S. James.
Grinberg L
AIDS Treat News; 1999 Nov; (No 330):2-4. PubMed ID: 11367171
[TBL] [Abstract][Full Text] [Related]
12. Adefovir dipivoxil (Preveon) expanded access restrictions being eased.
James JS
AIDS Treat News; 1998 Feb; (No 288):4-5. PubMed ID: 11365045
[TBL] [Abstract][Full Text] [Related]
13. Running a tightrope: regulatory challenges in the development of antiretrovirals.
Naeger LK; Struble KA; Murray JS; Birnkrant DB
Antiviral Res; 2010 Jan; 85(1):232-40. PubMed ID: 19665489
[TBL] [Abstract][Full Text] [Related]
14. FDA explores new antiretroviral trial designs: interview with David Feigal, M.D. Interview by John S. James.
Feigal D
AIDS Treat News; 1997 Jun; (No 273):1-5. PubMed ID: 11364399
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
16. The science and marketing of simpler dosing.
Proj Inf Perspect; 1997 Nov; (23):6-7. PubMed ID: 11365380
[TBL] [Abstract][Full Text] [Related]
17. Incremental drug treatment cost in HIV-positive patients in industry-sponsored clinical trials.
Perrín RS; López FJ
Ann Pharmacother; 2008 Nov; 42(11):1586-91. PubMed ID: 18780807
[TBL] [Abstract][Full Text] [Related]
18. FDA guidelines revised for combination HIV therapies.
AIDS Policy Law; 2004 Jun; 19(10):2. PubMed ID: 15202412
[No Abstract] [Full Text] [Related]
19. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
20. HIV resistance testing proves its value.
Proj Inf Perspect; 1999 Sep; (28):14. PubMed ID: 11367356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]